Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-21

Clinical Trial Update: Effect of Sublingual Immunotherapy on Platlet factor4 Level in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating effects of sublingual immunotherapy on Platelet Factor 4 levels in children with allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sublingual immunotherapy (Sublingual immunotherapy)

Snippet

Sponsor: Zagazig University | Conditions: Allergic Rhinitis | Phase 3 | Status: UNKNOWN